ES554166A0 - Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos. - Google Patents

Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Info

Publication number
ES554166A0
ES554166A0 ES554166A ES554166A ES554166A0 ES 554166 A0 ES554166 A0 ES 554166A0 ES 554166 A ES554166 A ES 554166A ES 554166 A ES554166 A ES 554166A ES 554166 A0 ES554166 A0 ES 554166A0
Authority
ES
Spain
Prior art keywords
pharmaces
discharge
manufacture method
distributor device
controlled speed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554166A
Other languages
English (en)
Other versions
ES8801114A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES554166A0 publication Critical patent/ES554166A0/es
Publication of ES8801114A1 publication Critical patent/ES8801114A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES554166A 1985-04-22 1986-04-18 Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos. Expired ES8801114A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,839 US4624847A (en) 1985-04-22 1985-04-22 Drug delivery device for programmed delivery of beneficial drug

Publications (2)

Publication Number Publication Date
ES554166A0 true ES554166A0 (es) 1987-12-16
ES8801114A1 ES8801114A1 (es) 1987-12-16

Family

ID=24916166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554166A Expired ES8801114A1 (es) 1985-04-22 1986-04-18 Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Country Status (9)

Country Link
US (1) US4624847A (es)
JP (1) JPS61280418A (es)
CA (1) CA1267089A (es)
CH (1) CH667589A5 (es)
DE (1) DE3613454A1 (es)
ES (1) ES8801114A1 (es)
FR (1) FR2580501B1 (es)
GB (1) GB2173704B (es)
IT (2) IT1188097B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
JPS63250488A (ja) * 1987-04-06 1988-10-18 Murata Mfg Co Ltd めつき処理方法
US5499979A (en) * 1987-06-25 1996-03-19 Alza Corporation Delivery system comprising kinetic forces
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4957494A (en) * 1987-06-25 1990-09-18 Alza Corporation Multi-layer delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US5803712A (en) 1988-05-17 1998-09-08 Patient Solutions, Inc. Method of measuring an occlusion in an infusion device with disposable elements
US5074756A (en) 1988-05-17 1991-12-24 Patient Solutions, Inc. Infusion device with disposable elements
US5246347A (en) 1988-05-17 1993-09-21 Patients Solutions, Inc. Infusion device with disposable elements
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
WO1992007525A1 (en) * 1990-10-31 1992-05-14 Baxter International Inc. Close vascularization implant material
US5545223A (en) * 1990-10-31 1996-08-13 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
WO1995008289A2 (en) 1993-09-16 1995-03-30 Scimed Life Systems, Inc. Percutaneous repair of cardiovascular anomalies and repair compositions
JPH08503715A (ja) * 1993-09-24 1996-04-23 バクスター、インターナショナル、インコーポレイテッド 埋め込み装置の血管化を促進するための方法
US5792106A (en) * 1993-12-02 1998-08-11 Scimed Life Systems, Inc. In situ stent forming catheter
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US6156305A (en) * 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
US5733270A (en) * 1995-06-07 1998-03-31 Baxter International Inc. Method and device for precise release of an antimicrobial agent
US5869078A (en) * 1996-04-25 1999-02-09 Medtronic Inc. Implantable variable permeability drug infusion techniques
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
ATE373957T1 (de) 1997-10-09 2007-10-15 Univ Emory Verfahren und vorrichtung zur transdermalen verabreichung von lithium
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CA2395333C (en) * 1999-12-23 2009-01-13 Pfizer Products Inc. Hydrogel-driven drug dosage form
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
AU2002221412B2 (en) 2000-12-05 2006-04-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
WO2003099214A2 (en) * 2002-05-23 2003-12-04 Andrx Corporation Biguanide formulations
CA2489325C (en) * 2002-06-17 2010-08-10 Alza Corporation Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US8734850B2 (en) * 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
EP2041214A4 (en) 2006-07-10 2009-07-08 Medipacs Inc SUPERELASTIC EPOXY HYDROGEL
EP2227635A2 (en) 2007-12-03 2010-09-15 Medipacs, Inc. Fluid metering device
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
CA2757979A1 (en) * 2009-04-09 2010-10-14 Alkermes Pharma Ireland Limited Controlled-release clozapine compositions
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
US8668675B2 (en) 2010-11-03 2014-03-11 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
EP2847249A4 (en) 2012-03-14 2016-12-28 Medipacs Inc SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES
PE20151431A1 (es) 2013-01-09 2015-09-23 Edgemont Pharmaceuticals Llc Formulaciones de lorazepam de liberacion controlada
US8999393B1 (en) 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4203439A (en) * 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4210139A (en) * 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
IT1188097B (it) 1987-12-30
IT8653309V0 (it) 1986-04-21
FR2580501A1 (fr) 1986-10-24
JPH0428242B2 (es) 1992-05-13
CH667589A5 (de) 1988-10-31
ES8801114A1 (es) 1987-12-16
CA1267089A (en) 1990-03-27
IT8667331A0 (it) 1986-04-21
JPS61280418A (ja) 1986-12-11
DE3613454A1 (de) 1986-10-23
US4624847A (en) 1986-11-25
FR2580501B1 (fr) 1990-08-10
GB2173704A (en) 1986-10-22
GB2173704B (en) 1989-08-23
GB8609218D0 (en) 1986-05-21

Similar Documents

Publication Publication Date Title
ES554166A0 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES554167A0 (es) Metodo para la fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES554165A0 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES556477A0 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de un farmaco beneficioso.
ES556147A0 (es) Metodo de fabricacion de un nuevo sistema para la descarga a velocidad controlada de un farmaco beneficioso.
ES556375A0 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de farmacos beneficiosos
ES545366A0 (es) Metodo para la fabricacion de dispositivos de liberacion a velocidad controlada de agentes beneficiosos.
ES539852A0 (es) Un nuevo procedimiento para la preparacion de nuevos derivados. de carbazolona.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES513287A0 (es) "un metodo con su aparato correspondiente, para la limpieza de electrodos".
ES517296A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES530393A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.
ES549180A0 (es) Un metodo para preparar nuevos derivados de cefem
ES528079A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
BR8201123A (pt) Bocal de dupla funcao para um sistema de lubrificacao
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES517295A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES523501A0 (es) "un metodo para preparar derivados de 3-metilflavona".
ES503015A0 (es) Un procedimiento para la preparacion de nuevos derivados delindeno.
ES516184A0 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
ES514141A0 (es) Un procedimiento para la produccion de un nuevo antibiotico.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519